LUNG insider trading — Pulmonx Corp
Over the last 90 days, insiders at Pulmonx Corp (LUNG) made 0 open-market purchases worth $0 and 4 open-market sales worth $177K, making them net sellers by $177K. The largest sale was by French Glendon E. Iii (President and CEO), who sold 41,882 shares for $95K on Sep 1, 2026.
Updated Oct 16, 2026.
Recent LUNG insider transactions
Every Form 4 filed by Pulmonx Corp officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | French Glendon E. Iii | President and CEO | S · Sale | Direct | 41,882 | $2.26 | $95K | Form 4 |
| Sep 1, 2026 | Radhakrishnan Srikanth | Chief Science & Techn. Officer | S · Sale | Direct | 14,245 | $2.26 | $32K | Form 4 |
| Sep 1, 2026 | Lehman David Aaron | General Counsel | S · Sale | Direct | 14,334 | $2.26 | $32K | Form 4 |
| Sep 1, 2026 | Rose Geoffrey Beran | Chief Commercial Officer | S · Sale | Direct | 7,879 | $2.26 | $18K | Form 4 |
LUNG insider trading FAQ
Are insiders buying LUNG stock?
Not on the open market. In the last 90 days, Pulmonx Corp insiders made no open-market purchases, and 4 open-market sales totaling $177K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading LUNG?
Recent sellers: French Glendon E. Iii, Lehman David Aaron, Radhakrishnan Srikanth, Rose Geoffrey Beran.
Where does LUNG insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.